Literature DB >> 25066236

Pseudomonas aeruginosa AmpR: an acute-chronic switch regulator.

Deepak Balasubramanian1, Hansi Kumari2, Kalai Mathee3.   

Abstract

Pseudomonas aeruginosa is one of the most intractable human pathogens that pose serious clinical challenge due to extensive prevalence of multidrug-resistant clinical isolates. Armed with abundant virulence and antibiotic resistance mechanisms, it is a major etiologic agent in a number of acute and chronic infections. A complex and intricate network of regulators dictates the expression of pathogenicity factors in P. aeruginosa. Some proteins within the network play key roles and control multiple pathways. This review discusses the role of one such protein, AmpR, which was initially recognized for its role in antibiotic resistance by regulating AmpC β-lactamase. Recent genomic, proteomic and phenotypic analyses demonstrate that AmpR regulates expression of hundreds of genes that are involved in diverse pathways such as β-lactam and non-β-lactam resistance, quorum sensing and associated virulence phenotypes, protein phosphorylation, and physiological processes. Finally, ampR mutations in clinical isolates are reviewed to shed light on important residues required for its function in antibiotic resistance. The prevalence and evolutionary implications of AmpR in pathogenic and nonpathogenic proteobacteria are also discussed. A comprehensive understanding of proteins at nodal positions in the P. aeruginosa regulatory network is crucial in understanding, and ultimately targeting, the pathogenic stratagems of this organism. © FEMS 2014. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Pseudomonas aeruginosa virulence; antibiotic resistance; c-di-GMP; global regulator; quorum sensing; ser/thr protein phosphorylation

Mesh:

Substances:

Year:  2015        PMID: 25066236      PMCID: PMC4542883          DOI: 10.1111/2049-632X.12208

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  153 in total

1.  Genome-wide identification of novel small RNAs in Pseudomonas aeruginosa.

Authors:  María Gómez-Lozano; Rasmus Lykke Marvig; Søren Molin; Katherine S Long
Journal:  Environ Microbiol       Date:  2012-04-26       Impact factor: 5.491

2.  Direct interaction between sensor kinase proteins mediates acute and chronic disease phenotypes in a bacterial pathogen.

Authors:  Andrew L Goodman; Massimo Merighi; Mamoru Hyodo; Isabelle Ventre; Alain Filloux; Stephen Lory
Journal:  Genes Dev       Date:  2009-01-15       Impact factor: 11.361

Review 3.  Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.

Authors:  Philip D Lister; Daniel J Wolter; Nancy D Hanson
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

Review 4.  Emerging infections in burns.

Authors:  Ludwik K Branski; Ahmed Al-Mousawi; Haidy Rivero; Marc G Jeschke; Arthur P Sanford; David N Herndon
Journal:  Surg Infect (Larchmt)       Date:  2009-10       Impact factor: 2.150

Review 5.  The type III secretion system of Pseudomonas aeruginosa: infection by injection.

Authors:  Alan R Hauser
Journal:  Nat Rev Microbiol       Date:  2009-09       Impact factor: 60.633

6.  Genomic variation among contemporary Pseudomonas aeruginosa isolates from chronically infected cystic fibrosis patients.

Authors:  Jade C S Chung; Jennifer Becq; Louise Fraser; Ole Schulz-Trieglaff; Nicholas J Bond; Juliet Foweraker; Kenneth D Bruce; Geoffrey P Smith; Martin Welch
Journal:  J Bacteriol       Date:  2012-06-29       Impact factor: 3.490

7.  Genomics of adaptation during experimental evolution of the opportunistic pathogen Pseudomonas aeruginosa.

Authors:  Alex Wong; Nicolas Rodrigue; Rees Kassen
Journal:  PLoS Genet       Date:  2012-09-13       Impact factor: 5.917

8.  Small RNA as global regulator of carbon catabolite repression in Pseudomonas aeruginosa.

Authors:  Elisabeth Sonnleitner; Laetitia Abdou; Dieter Haas
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

9.  Assembly and development of the Pseudomonas aeruginosa biofilm matrix.

Authors:  Luyan Ma; Matthew Conover; Haiping Lu; Matthew R Parsek; Kenneth Bayles; Daniel J Wozniak
Journal:  PLoS Pathog       Date:  2009-03-27       Impact factor: 6.823

10.  Beta-lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein.

Authors:  Bartolomé Moya; Andreas Dötsch; Carlos Juan; Jesús Blázquez; Laura Zamorano; Susanne Haussler; Antonio Oliver
Journal:  PLoS Pathog       Date:  2009-03-27       Impact factor: 6.823

View more
  26 in total

1.  Iminoguanidines as Allosteric Inhibitors of the Iron-Regulated Heme Oxygenase (HemO) of Pseudomonas aeruginosa.

Authors:  Geoffrey A Heinzl; Weiliang Huang; Wenbo Yu; Bennett J Giardina; Yue Zhou; Alexander D MacKerell; Angela Wilks; Fengtian Xue
Journal:  J Med Chem       Date:  2016-07-11       Impact factor: 7.446

2.  Muropeptide Binding and the X-ray Structure of the Effector Domain of the Transcriptional Regulator AmpR of Pseudomonas aeruginosa.

Authors:  David A Dik; Teresa Domínguez-Gil; Mijoon Lee; Dusan Hesek; Byungjin Byun; Jennifer Fishovitz; Bill Boggess; Lance M Hellman; Jed F Fisher; Juan A Hermoso; Shahriar Mobashery
Journal:  J Am Chem Soc       Date:  2017-01-17       Impact factor: 15.419

3.  Uncoupled Quorum Sensing Modulates the Interplay of Virulence and Resistance in a Multidrug-Resistant Clinical Pseudomonas aeruginosa Isolate Belonging to the MLST550 Clonal Complex.

Authors:  Tingying Xia; Yanran Li; Zeling Xu; Huiluo Cao; Salim Bougouffa; Yat Kei Lo; Vladimir B Bajic; Haiwei Luo; Patrick C Y Woo; Aixin Yan
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

4.  Complex Regulation Pathways of AmpC-Mediated β-Lactam Resistance in Enterobacter cloacae Complex.

Authors:  François Guérin; Christophe Isnard; Vincent Cattoir; Jean Christophe Giard
Journal:  Antimicrob Agents Chemother       Date:  2015-10-05       Impact factor: 5.191

Review 5.  Constructing and deconstructing the bacterial cell wall.

Authors:  Jed F Fisher; Shahriar Mobashery
Journal:  Protein Sci       Date:  2019-11-20       Impact factor: 6.725

6.  Ceftazidime-Avibactam in Combination With Fosfomycin: A Novel Therapeutic Strategy Against Multidrug-Resistant Pseudomonas aeruginosa.

Authors:  Krisztina M Papp-Wallace; Elise T Zeiser; Scott A Becka; Steven Park; Brigid M Wilson; Marisa L Winkler; Roshan D'Souza; Indresh Singh; Granger Sutton; Derrick E Fouts; Liang Chen; Barry N Kreiswirth; Evelyn J Ellis-Grosse; George L Drusano; David S Perlin; Robert A Bonomo
Journal:  J Infect Dis       Date:  2019-07-19       Impact factor: 5.226

Review 7.  Lytic transglycosylases: concinnity in concision of the bacterial cell wall.

Authors:  David A Dik; Daniel R Marous; Jed F Fisher; Shahriar Mobashery
Journal:  Crit Rev Biochem Mol Biol       Date:  2017-06-23       Impact factor: 8.250

8.  Agmatine accumulation by Pseudomonas aeruginosa clinical isolates confers antibiotic tolerance and dampens host inflammation.

Authors:  Jennifer L McCurtain; Adam J Gilbertsen; Clayton Evert; Bryan J Williams; Ryan C Hunter
Journal:  J Med Microbiol       Date:  2019-01-22       Impact factor: 2.472

9.  Muropeptides in Pseudomonas aeruginosa and their Role as Elicitors of β-Lactam-Antibiotic Resistance.

Authors:  Mijoon Lee; Supurna Dhar; Stefania De Benedetti; Dusan Hesek; Bill Boggess; Blas Blázquez; Kalai Mathee; Shahriar Mobashery
Journal:  Angew Chem Int Ed Engl       Date:  2016-04-25       Impact factor: 15.336

10.  Controlling chronic Pseudomonas aeruginosa infections by strategically interfering with the sensory function of SagS.

Authors:  Jozef Dingemans; Rebecca E Al-Feghali; Gee W Lau; Karin Sauer
Journal:  Mol Microbiol       Date:  2019-03-26       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.